Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767881 · ClinicalTrials.gov registry record · NA
AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03767881 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 30 participants.
The verdict
NCT03767881, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the AXIOS™ Stent with Electrocautery Enhanced Delivery System in the management of symptoms of acute cholecystitis as an alternative to percutaneous gallbladder drainage.
Interventions
- DEVICE AXIOS(TM) Stent and Electrocautery Enhanced Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-09-10 |
| Est. Completion | 2021-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03767881
The ClinicalTrials.gov registry entry for NCT03767881 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AXIOS(TM) Stent and Electrocautery Enhanced Delivery System is the first listed.
NCT03767881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03767881 about?
NCT03767881 is a clinical study titled "AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE". To evaluate the safety and effectiveness of the AXIOS™ Stent with Electrocautery Enhanced Delivery System in the management of symptoms of acute cholecystitis as an alternative to percutaneous gallbladder drainage.
What is the current status of trial NCT03767881?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-09-10. Estimated completion is 2021-12-02.
What interventions are being tested in trial NCT03767881?
The interventions under investigation include: AXIOS(TM) Stent and Electrocautery Enhanced Delivery System (DEVICE).
Who is sponsoring clinical trial NCT03767881?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.